- About Breast Cancer
- Community Impact
- Get Involved
OUR IMPACT IN THE MISSION TO END BREAST CANCER
WHERE DO OUR PROCEEDS GO?
Oncotype DX® is it right for you? Along with other factors, the results of the Oncotype DX test help predict the chance of metastasis.Virginian Pilot – Power of Pink
Send in your survivor story; the story of a loved one; or the story of an individual or group who have made an impact in the fight against breast cancer.SEE ALL NEWS
TailorRX study shows chemotherapy not needed for some breast cancer patients. Hear from our very own Dr. Sledge. Watch Now!Metastatic Breast Cancer
Komen has invested more than $180 million into research on metastatic breast cancer. Find out what we’ve learned and what we’re investigating. Read more now!